Medical Equipment

Bilirubin Blood Test Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

March 10, 2026March 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Bilirubin Blood Test Market By The End Of 2030?

The bilirubin blood test market has experienced substantial growth in recent years. It is anticipated to expand from $1.46 billion in 2025 to $1.57 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. This historical expansion is largely due to factors such as an increase in neonatal jaundice screening programs, a rise in hospital-based liver function testing, enhanced diagnostic awareness regarding liver disorders, the integration of serum bilirubin testing into routine clinical practice, and the broadening of pediatric and infant diagnostic services.

The bilirubin blood test market is anticipated to experience substantial expansion in the coming years, with its size projected to reach $2.08 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period is driven by factors such as the increasing incidence of chronic liver disease and hepatitis, a growing demand for early assessment of liver health, the rising adoption of bilirubin testing in primary care environments, higher rates of testing among aging and high-risk patient populations, and the proliferation of point-of-care and specialized liver diagnostics. Significant trends expected during this period include an intensified application of bilirubin testing for evaluating liver function, the expanding use of bilirubin tests in screening for neonatal jaundice, an increased requirement for testing in hematology and pre-liver disorder evaluations, the broader deployment of bilirubin monitoring across hospital and clinical settings, and a strategic focus on early detection and routine screening for liver wellness.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

What Drivers Are Shaping The Future Growth Of The Bilirubin Blood Test Market?

The escalating prevalence of liver diseases is projected to drive the expansion of the bilirubin blood test market in the future. Liver diseases encompass a spectrum of conditions that compromise the liver’s proper functioning, potentially arising from various factors such as infections, alcohol abuse, or metabolic disorders. The increasing incidence of liver disease cases can be attributed to rising rates of obesity, excessive alcohol consumption, viral infections, and unhealthy lifestyle choices, which collectively contribute to liver dysfunction and damage. Such conditions can significantly affect bilirubin levels within the body, and bilirubin blood tests are instrumental in diagnosing and monitoring liver function, thereby offering crucial insights into patient health and assisting healthcare providers in the effective management and treatment of liver-related conditions. For instance, in April 2023, according to GOV.UK, a UK-based department for science, innovation, and technology, hospital admission rates for liver disease increased from 150.6 (148.2–152.9) to 155.2 (152.9–157.5) per 100,000 population between the financial years ending 2022 and 2023, underscoring a continued upward trend in liver disease-related hospitalizations. Hence, the increasing occurrences of liver diseases are a significant driver for the bilirubin blood test market.

Which Segment Classifications Shape The Bilirubin Blood Test Market?

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

How Are Trends Impacting The Bilirubin Blood Test Market?

Leading firms within the bilirubin blood test market are employing a strategic partnership strategy to broaden their market presence and augment their service portfolio. Such a partnership generally denotes a cooperative arrangement involving two or more entities pooling their resources, knowledge, and endeavors to reach shared aims or targets. As an illustration, Calmark Sweden AB, a medical diagnostic biotechnology solutions company based in Israel, entered into an exclusive distributor agreement with Techno Orbits in Saudi Arabia in December 2023, specifically for Calmark’s bilirubin test intended for newborns. Techno Orbits is set to manage the product’s distribution and sales, utilizing its established network and connections, including those with the Ministry of Health. The objective of this collaboration is to streamline the entry of Calmark’s bilirubin test into the Saudi market, with regulatory registration projected to conclude within 3 to 6 months.

Which Companies Are Expanding Their Footprint In The Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMérieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High-Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

Read the full bilirubin blood test market report here:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Geographic Regions Are Influencing Demand In The Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2025. The regions covered in the bilirubin blood test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bilirubin Blood Test Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2026, By The Business Research Company

Bilirubin Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/bilirubin-meters-global-market-report

Hemoglobin Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Hemoglobin A1C Hba1C Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795